array(3) {
["company_details"]=>
array(13) {
["name"]=>
string(26) "Bio-RAD Laboratories, Inc."
["slug"]=>
string(33) "001cd-us-bio-rad-laboratories-inc"
["logo"]=>
string(84) "https://images.businessradar.com/linkedin_logos/9d1c28c2-1b47-4093-8ed2-5151f3fe7920"
["description"]=>
string(867) "Since Bio-Rad was founded 70 years ago, we have continued to provide the healthcare industry with innovative and useful products that help life science researchers accelerate the discovery process and medical diagnostic labs obtain faster, better results. Throughout our existence, we have built long-lasting customer relationships that help advance our research and development efforts in the introduction of new products and solutions. Today, Bio-Rad is a global leader, with a team of over 8,000 employees and a global network of operations that serves our life science research and clinical diagnostics customers, advancing science and saving lives, together.
#Biotechnology #Biotech #STEM #Research #Biology #Chemistry #Science #PeerReviewed #Diabetes #CancerResearch #HIVResearch #Laboratory #BioRad #Cancer #DiabetesResearch #AIDSResearch #ClinicalDiagnostics"
["address_street"]=>
string(20) "1000 Alfred Nobel Dr"
["address_place"]=>
string(8) "Hercules"
["address_region"]=>
string(10) "California"
["founding_date"]=>
string(10) "1952-02-08"
["website_domain"]=>
string(11) "bio-rad.com"
["website_url"]=>
string(23) "https://www.bio-rad.com"
["industry_codes"]=>
array(3) {
[0]=>
string(42) "In Vitro and In Vivo Diagnostic Substances"
[1]=>
string(33) "Laboratory Analytical Instruments"
[2]=>
string(47) "Electromedical and Electrotherapeutic Apparatus"
}
["employee_count"]=>
int(7900)
["article_count"]=>
int(661)
}
["articles"]=>
array(9) {
[0]=>
array(7) {
["title_en"]=>
string(145) "Bio-Rad launches first Ultrasensitive Multiplexed Digital PCR Assay for breast cancer mutation detection in clinical research | Cambridge Network"
["snippet_en"]=>
string(204) "Highly Sensitive and Multiplexed Assay for the Detection, Discrimination, and Quantification of Key Mutations in ESR1 Gene for Breast Cancer, Developed for Bio-Rad’s QX600TM Droplet DigitalTM PCR System"
["url"]=>
string(130) "https://www.cambridgenetwork.co.uk/news/bio-rad-launches-first-ultrasensitive-multiplexed-digital-pcr-assay-breast-cancer-mutation"
["image_url"]=>
NULL
["source"]=>
string(22) "cambridgenetwork.co.uk"
["publication_date"]=>
string(10) "2024-04-03"
["categories"]=>
array(4) {
[0]=>
string(5) "Legal"
[1]=>
string(14) "Product Launch"
[2]=>
string(5) "R & D"
[3]=>
string(10) "New Market"
}
}
[1]=>
array(7) {
["title_en"]=>
string(73) "Bio-Rad launches third in series of educational quality control workbooks"
["snippet_en"]=>
string(79) "Cost of Quality takes center stage in latest installment of educational series."
["url"]=>
string(128) "https://www.mlo-online.com/management/article/53096252/bio-rad-launches-third-in-series-of-educational-quality-control-workbooks"
["image_url"]=>
string(78) "https://images.businessradar.com/articles/17475f36-13eb-443b-89ae-4a573ca3e932"
["source"]=>
string(14) "mlo-online.com"
["publication_date"]=>
string(10) "2024-02-12"
["categories"]=>
array(3) {
[0]=>
string(14) "Product Launch"
[1]=>
string(10) "New Market"
[2]=>
string(37) "Product Design & Lifecycle Management"
}
}
[2]=>
array(7) {
["title_en"]=>
string(43) "Bio-Rad Launches First StarBrightTM Red Dye"
["snippet_en"]=>
string(143) "With 29 additional targets the range also includes dog, cow, and pig targets to support translational models in veterinary immunology research."
["url"]=>
string(223) "https://www.the-scientist.com/the-marketplace/bio-rad-launches-first-starbright-red-dye-and-extends-range-of-antibody-markers-conjugated-to-starbright-dyes-to-enhance-multiplex-flow-cytometry-and-research-capabilities-71322"
["image_url"]=>
string(78) "https://images.businessradar.com/articles/6dd64ccc-ba21-4374-b508-13fc7b055a2d"
["source"]=>
string(17) "the-scientist.com"
["publication_date"]=>
string(10) "2023-08-29"
["categories"]=>
array(2) {
[0]=>
string(14) "Product Launch"
[1]=>
string(10) "New Market"
}
}
[3]=>
array(7) {
["title_en"]=>
string(56) "Procalcitonin tests market in Brazil: market size trends"
["snippet_en"]=>
string(93) "According to GlobalData, the procalcitonin tests market in Brazil was valued at 10.60 in 2022"
["url"]=>
string(91) "https://www.medicaldevice-network.com/data-insights/procalcitonin-tests-brazil-market-size/"
["image_url"]=>
NULL
["source"]=>
string(25) "medicaldevice-network.com"
["publication_date"]=>
string(10) "2023-08-03"
["categories"]=>
array(5) {
[0]=>
string(11) "Competition"
[1]=>
string(15) "Market Movement"
[2]=>
string(5) "R & D"
[3]=>
string(21) "Competitive Behaviour"
[4]=>
string(10) "New Market"
}
}
[4]=>
array(7) {
["title_en"]=>
string(52) "Diabetes assays market in Mexico: market size trends"
["snippet_en"]=>
string(89) "According to GlobalData, the diabetes assays market in Mexico was valued at 38.60 in 2022"
["url"]=>
string(87) "https://www.medicaldevice-network.com/uncategorized/diabetes-assays-mexico-market-size/"
["image_url"]=>
NULL
["source"]=>
string(25) "medicaldevice-network.com"
["publication_date"]=>
string(10) "2023-07-28"
["categories"]=>
array(5) {
[0]=>
string(11) "Competition"
[1]=>
string(15) "Market Movement"
[2]=>
string(5) "R & D"
[3]=>
string(21) "Competitive Behaviour"
[4]=>
string(10) "New Market"
}
}
[5]=>
array(7) {
["title_en"]=>
string(89) "Bio-Rad Launches Its CFX Opus Dx Real-Time PCR Detection Systems for In Vitro Diagnostics"
["snippet_en"]=>
string(169) "The CFX Opus 96 Dx System and the CFX Opus 384 Dx Real-Time PCR Systems Offer Accurate and Precise Quantification to Improve IVD Assay Development and Diagnostic Testing"
["url"]=>
string(141) "https://www.the-scientist.com/the-marketplace/bio-rad-launches-its-cfx-opus-dx-real-time-pcr-detection-systems-for-in-vitro-diagnostics-69410"
["image_url"]=>
string(78) "https://images.businessradar.com/articles/fe72a9a3-3839-4ab4-80ca-c72eb5dbdfc4"
["source"]=>
string(17) "the-scientist.com"
["publication_date"]=>
string(10) "2021-11-11"
["categories"]=>
array(2) {
[0]=>
string(14) "Product Launch"
[1]=>
string(10) "New Market"
}
}
[6]=>
array(7) {
["title_en"]=>
string(77) "Bio-Rad launches its reliance SARS-CoV-2/FluA/FluB RT-PCR assay kit in Europe"
["snippet_en"]=>
string(274) "Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader of life science research and clinical diagnostic products, today announced the launch of the Reliance SARS-CoV-2/FluA/FluBTM RT-PCR Kit (IVD) for European markets after having met the CE-IVD mark requirements."
["url"]=>
string(117) "https://www.biotechniques.com/covid-19/bio-rad-launches-its-reliance-sars-cov-2-flua-flub-rt-pcr-assay-kit-in-europe/"
["image_url"]=>
string(78) "https://images.businessradar.com/articles/b7b2a415-5b7c-4b0b-bb1b-a8d5dd6235d2"
["source"]=>
string(17) "biotechniques.com"
["publication_date"]=>
string(10) "2021-07-21"
["categories"]=>
array(2) {
[0]=>
string(14) "Product Launch"
[1]=>
string(10) "New Market"
}
}
[7]=>
array(7) {
["title_en"]=>
string(106) "Bio-Rad Launches Reliance One-Step Multiplex Supermix for Pathogen Detection and High-Throughput Screening"
["snippet_en"]=>
string(217) "Bio-Rad Laboratories, Inc. announced the launch of the Reliance One-Step Multiplex Supermix, a highly sensitive and robust reagent mix for detection and quantification of up to five RNA or DNA targets in one reaction."
["url"]=>
string(161) "https://www.technologynetworks.com/biopharma/product-news/bio-rad-launches-reliance-one-step-multiplex-supermix-for-pathogen-detection-and-high-throughput-322683"
["image_url"]=>
NULL
["source"]=>
string(22) "technologynetworks.com"
["publication_date"]=>
string(10) "2019-08-09"
["categories"]=>
array(2) {
[0]=>
string(14) "Product Launch"
[1]=>
string(10) "New Market"
}
}
[8]=>
array(7) {
["title_en"]=>
string(138) "Bio-Rad Launches iQ-Check Real-Time PCR Kit, a Fast PCR Alternative for Detection of Aspergillus in Cannabis and Cannabis-Infused Products"
["snippet_en"]=>
string(71) "Detection of Aspergillus spp. in Cannabis and Cannabis-Infused Products"
["url"]=>
string(188) "https://www.labmanager.com/bio-rad-launches-iq-check-i-aspergillus-i-real-time-pcr-kit-a-fast-pcr-alternative-for-detection-of-i-aspergillus-i-in-cannabis-and-cannabis-infused-products-489"
["image_url"]=>
string(78) "https://images.businessradar.com/articles/ee0c4e21-bd91-43bb-8631-e51d99ef0330"
["source"]=>
string(14) "labmanager.com"
["publication_date"]=>
NULL
["categories"]=>
array(3) {
[0]=>
string(10) "New Market"
[1]=>
string(14) "Product Launch"
[2]=>
string(11) "Competition"
}
}
}
["category_annotations"]=>
array(30) {
[0]=>
array(2) {
["name"]=>
string(12) "Stock Market"
["count"]=>
int(66)
}
[1]=>
array(2) {
["name"]=>
string(24) "Quarterly/Annual Figures"
["count"]=>
int(51)
}
[2]=>
array(2) {
["name"]=>
string(14) "Product Launch"
["count"]=>
int(31)
}
[3]=>
array(2) {
["name"]=>
string(15) "Market Movement"
["count"]=>
int(28)
}
[4]=>
array(2) {
["name"]=>
string(5) "Legal"
["count"]=>
int(26)
}
[5]=>
array(2) {
["name"]=>
string(17) "Academic Research"
["count"]=>
int(24)
}
[6]=>
array(2) {
["name"]=>
string(31) "Financial Update/Profit Warning"
["count"]=>
int(23)
}
[7]=>
array(2) {
["name"]=>
string(18) "General Investment"
["count"]=>
int(20)
}
[8]=>
array(2) {
["name"]=>
string(8) "Epidemic"
["count"]=>
int(19)
}
[9]=>
array(2) {
["name"]=>
string(11) "Acquisition"
["count"]=>
int(19)
}
[10]=>
array(2) {
["name"]=>
string(5) "R & D"
["count"]=>
int(19)
}
[11]=>
array(2) {
["name"]=>
string(24) "Stock Research & Ratings"
["count"]=>
int(18)
}
[12]=>
array(2) {
["name"]=>
string(14) "Issuing Shares"
["count"]=>
int(14)
}
[13]=>
array(2) {
["name"]=>
string(10) "Litigation"
["count"]=>
int(14)
}
[14]=>
array(2) {
["name"]=>
string(18) "Ecological Impacts"
["count"]=>
int(13)
}
[15]=>
array(2) {
["name"]=>
string(13) "Collaboration"
["count"]=>
int(13)
}
[16]=>
array(2) {
["name"]=>
string(18) "Expansion & Growth"
["count"]=>
int(9)
}
[17]=>
array(2) {
["name"]=>
string(12) "Board Change"
["count"]=>
int(9)
}
[18]=>
array(2) {
["name"]=>
string(10) "New Market"
["count"]=>
int(9)
}
[19]=>
array(2) {
["name"]=>
string(11) "Regulations"
["count"]=>
int(9)
}
[20]=>
array(2) {
["name"]=>
string(21) "Competitive Behaviour"
["count"]=>
int(8)
}
[21]=>
array(2) {
["name"]=>
string(11) "Competition"
["count"]=>
int(7)
}
[22]=>
array(2) {
["name"]=>
string(27) "Business Model & Innovation"
["count"]=>
int(7)
}
[23]=>
array(2) {
["name"]=>
string(46) "Management of Legal and Regulatory Environment"
["count"]=>
int(7)
}
[24]=>
array(2) {
["name"]=>
string(6) "Merger"
["count"]=>
int(7)
}
[25]=>
array(2) {
["name"]=>
string(16) "Case Settlements"
["count"]=>
int(6)
}
[26]=>
array(2) {
["name"]=>
string(13) "Credit Rating"
["count"]=>
int(5)
}
[27]=>
array(2) {
["name"]=>
string(15) "Business Ethics"
["count"]=>
int(5)
}
[28]=>
array(2) {
["name"]=>
string(25) "Business Model Resilience"
["count"]=>
int(5)
}
[29]=>
array(2) {
["name"]=>
string(15) "Deals & Tenders"
["count"]=>
int(5)
}
}
}
001cd-us-bio-rad-laboratories-inc
Bio-RAD Laboratories, Inc.
Location
California
Founded
1952-02-08
Website
https://www.bio-rad.com
Articles
661 Articles
Category
In Vitro and In Vivo Diagnostic Substances
Laboratory Analytical Instruments
Electromedical and Electrotherapeutic Apparatus
Description
Since Bio-Rad was founded 70 years ago, we have continued to provide the healthcare industry with innovative and useful products that help life science researchers accelerate the discovery process and medical diagnostic labs obtain faster, better results. Throughout our existence, we have built long-lasting customer relationships that help advance our research and development efforts in the introduction of new products and solutions. Today, Bio-Rad is a global leader, with a team of over 8,000 employees and a global network of operations that serves our life science research and clinical diagnostics customers, advancing science and saving lives, together.
#Biotechnology #Biotech #STEM #Research #Biology #Chemistry #Science #PeerReviewed #Diabetes #CancerResearch #HIVResearch #Laboratory #BioRad #Cancer #DiabetesResearch #AIDSResearch #ClinicalDiagnostics
Highly Sensitive and Multiplexed Assay for the Detection, Discrimination, and Quantification of Key Mutations in ESR1 Gene for Breast Cancer, Developed for Bio-Rad’s QX600TM Droplet DigitalTM PCR System
The CFX Opus 96 Dx System and the CFX Opus 384 Dx Real-Time PCR Systems Offer Accurate and Precise Quantification to Improve IVD Assay Development and Diagnostic Testing
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader of life science research and clinical diagnostic products, today announced the launch of the Reliance SARS-CoV-2/FluA/FluBTM RT-PCR Kit (IVD) for European markets after having met the CE-IVD mark requirements.
Bio-Rad Laboratories, Inc. announced the launch of the Reliance One-Step Multiplex Supermix, a highly sensitive and robust reagent mix for detection and quantification of up to five RNA or DNA targets in one reaction.
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Functional
Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes.The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
